推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 8月13日，晶澳科技發(fā)布公告稱，公司全資子公司晶澳太陽(yáng)能與曲靖市人民政府、曲靖經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)管理委員會(huì)簽訂投資框架協(xié)議，就晶澳太陽(yáng)能在曲靖經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)建設(shè)20GW單晶拉棒及切片項(xiàng)目達(dá)成合作意向。
根據(jù)協(xié)議，晶澳太陽(yáng)能計(jì)劃投資約58億元，在曲靖經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)建設(shè)20GW單晶拉棒及切片項(xiàng)目。項(xiàng)目用地約700畝，選址在曲靖經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)南海子工業(yè)片區(qū)，并按規(guī)定享受?chē)?guó)家、省、市及經(jīng)開(kāi)區(qū)相關(guān)優(yōu)惠政策。
本次簽訂的項(xiàng)目投資框架協(xié)議符合公司未來(lái)產(chǎn)能規(guī)劃的戰(zhàn)略需要，充分利用當(dāng)?shù)貎?yōu)質(zhì)的電力資源和政策優(yōu)勢(shì)，進(jìn)一步提高公司生產(chǎn)能力，提升產(chǎn)品市場(chǎng)競(jìng)爭(zhēng)力。本次簽署的為框架協(xié)議，尚需簽訂正式投資協(xié)議。公司簽訂正式投資協(xié)議尚需按照規(guī)定履行董事會(huì)、股東大會(huì)等內(nèi)部審議程序。
